Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jason Aryeh currently holds 118,118 shares of LIGAND PHARMACEUTICALS INC (LGND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Aryeh has been a net seller of LGND stock. They have purchased $5.6M and sold $38.5M worth of shares.
Jason Aryeh's most recent insider trade was on May 18, 2026, when they purchased 665 shares at $3.75 per share.
Jason Aryeh serves as Executive at LIGAND PHARMACEUTICALS INC (LGND). They have executed 269 insider transactions totaling $44.1M over their tenure at the company.
Jason Aryeh holds the position of Executive at LIGAND PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Jason Aryeh has shown a selling trading pattern, with $5.6M in total purchases and $38.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jason Aryeh was on Aug 17, 2018, when they sold $6.5M worth of LGND shares. This transaction involved 26,862 shares at $241.81 per share.
Jason Aryeh currently owns 118,118 shares of LIGAND PHARMACEUTICALS INC (LGND), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jason Aryeh's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jason Aryeh has 269 Form 4 filings on record as an insider at LIGAND PHARMACEUTICALS INC.
Set alerts for Jason Aryeh and 40,000+ other insiders.